BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31954769)

  • 21. The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1.
    López-Huertas MR; Jiménez-Tormo L; Madrid-Elena N; Gutiérrez C; Rodríguez-Mora S; Coiras M; Alcamí J; Moreno S
    Sci Rep; 2017 May; 7(1):2385. PubMed ID: 28539614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
    Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
    Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-κB/NLRP3 signaling in a breast cancer mouse model.
    Wu Y; Che J; Dong J; Zhang X; Deng Y; Chen W; Zhang J
    Neuropharmacology; 2024 Aug; 254():109981. PubMed ID: 38704022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer.
    Chung KH; Cho IR; Paik WH; Kim YT; Lee SH; Ryu JK
    Anticancer Res; 2024 Mar; 44(3):1097-1108. PubMed ID: 38423644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.
    Ochoa-Callejero L; Pérez-Martínez L; Rubio-Mediavilla S; Oteo JA; Martínez A; Blanco JR
    PLoS One; 2013; 8(1):e53992. PubMed ID: 23326556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
    Chen X; Bui KC; Barat S; Thi Nguyen ML; Bozko P; Sipos B; Kalesse M; Malek NP; Plentz RR
    Cancer Lett; 2017 Jul; 399():20-28. PubMed ID: 28408354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells.
    Pervaiz A; Ansari S; Berger MR; Adwan H
    Med Oncol; 2015 May; 32(5):158. PubMed ID: 25840792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
    Zhao YM; Yang G; You L; Hu Y; Zhao YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
    [No Abstract]   [Full Text] [Related]  

  • 30. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
    Liu QH; Shi ML; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
    Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
    Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
    Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel small-molecular CCR5 antagonist promotes neural repair after stroke.
    Wu QL; Cui LY; Ma WY; Wang SS; Zhang Z; Feng ZP; Sun HS; Chu SF; He WB; Chen NH
    Acta Pharmacol Sin; 2023 Oct; 44(10):1935-1947. PubMed ID: 37198412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
    Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
    Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.
    Balasubramanian S; Chandraratna RA; Eckert RL
    Oncogene; 2005 Jun; 24(26):4257-70. PubMed ID: 15856029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment.
    Latinovic OS; Zhang J; Tagaya Y; DeVico AL; Fouts TR; Schneider K; Lakowicz JR; Heredia A; Redfield RR
    Curr HIV Res; 2016; 14(1):24-36. PubMed ID: 26354735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
    Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
    Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines.
    Zhivkova-Galunska M; Adwan H; Eyol E; Kleeff J; Kolb A; Bergmann F; Berger MR
    Cancer Biol Ther; 2010 Jul; 10(1):54-64. PubMed ID: 20495387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.